Multicomponent Composition Activating Nrf2 and NAD Pathways

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively activate cellular signaling pathways to maintain health and combat aging, particularly in addressing oxidative stress, mitochondrial inefficiency, and sirtuin activation, leading to diminished stress response and increased aging-related diseases.

Innovation Solution

Compositions and methods are disclosed to activate the Nrf2, NRF1, and NAD pathways by using specific combinations of ingredients such as theacrine, alpinia galanga, capsaicin, and mango leaf extract, which synergistically increase the expression of genes involved in antioxidant production, mitochondrial health, and sirtuin activation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to address oxidative stress and aging, then general health maintenance is attempted, but cellular signaling pathways (Nrf2, NRF1, NAD) are not effectively activated

Engineering Contradiction:
Improveeffectiveness of stress response activationVSAvoidactivation of cellular signaling pathways
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines multiple ingredients (theacrine, alpinia galanga, capsaicin, mango leaf extract) into a unified composition that synergistically activates Nrf2, NRF1, and NAD pathways. This merging of components creates a composite formulation where each ingredient contributes to different aspects of pathway activation, resolving the contradiction by achieving reliable pathway activation through combined action rather than single-agent approaches.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention employs a composite composition containing specifically selected natural compounds and extracts. This composite material approach allows the formulation to simultaneously target multiple cellular signaling pathways (Nrf2 for antioxidant response, NRF1 for mitochondrial function, NAD for sirtuin activation), thereby effectively activating stress response mechanisms that conventional single-ingredient methods fail to achieve.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If stress response pathways are not activated, then aging-related diseases increase, but current compositions fail to sufficiently activate Nrf2, NRF1, and NAD genes

Engineering Contradiction:
Improveaging-related diseases and oxidative stressVSAvoidgene expression activation
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent utilizes parameter changes by optimizing the concentrations and ratios of specific ingredients (theacrine, alpinia galanga, capsaicin, mango leaf extract) to achieve threshold levels necessary for effective gene expression. By adjusting these compositional parameters, the formulation reliably activates Nrf2, NRF1, and NAD pathways, thereby reducing oxidative stress and aging-related harmful effects that conventional compositions fail to address.

Inventive Principle:
Principle #35Parameter changes

3Use of energy by moving object

If mitochondrial inefficiency is not addressed, then cellular energy production declines, but existing methods do not effectively activate mitochondrial biogenesis pathways

Engineering Contradiction:
Improvemitochondrial energy productionVSAvoidmitochondrial function improvement
Core Design Contradiction:
Use of energy by moving objectVSReliability

Solution Approach 1:

The patent employs intermediary compounds (specifically alpinia galanga and other ingredients) that mediate between the administered composition and mitochondrial function. These intermediaries act as signaling molecules that trigger mitochondrial biogenesis and improve mitochondrial efficiency, thereby reliably enhancing cellular energy production without requiring direct manipulation of mitochondrial structures.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS11484563B2Compositions and methods for activating cellular signaling pathways
Publication Date: 2022.11.01 LIFEVANTAGE CORP
  • US11484563B2 patent drawing
  • US11484563B2 patent drawing
  • US11484563B2 patent drawing

AI summary

Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.